J&J’s Consumer Health Business Officially Goes Public
0
The spinoff of Johnson & Johnson’s consumer health business started trading at $22, at a roughly $42 billion valuation.
The spinoff of Johnson & Johnson’s consumer health business started trading at $22, at a roughly $42 billion valuation.